Covered recipient · General Payments record
INES JOAN SANCHEZ-RIVERA
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$27,447.87
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $976.18 | 9 |
| Education | $177.22 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Genmab U.S., Inc. | $249.98 | 2 |
| Gilead Sciences, Inc. | $207.41 | 2 |
| Regeneron Healthcare Solutions, Inc. | $138.85 | 2 |
| Acerta Pharma LLC | $121.84 | 1 |
| ABBVIE INC. | $103.10 | 1 |
| AVEO Pharmaceuticals, Inc. | $99.95 | 1 |
| Janssen Biotech, Inc. | $91.22 | 1 |
| BeiGene USA, Inc. | $80.80 | 1 |
| Merck Sharp & Dohme Corporation | $32.55 | 3 |
| PFIZER INC. | $27.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $103.10 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106012993 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.84 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105864702 | CMS |
| Aveo Pharmaceuticals, Inc. | $99.95 | 06/03/2024 | Education | Undisputed | 01/23/2026 | 1143478816 | CMS |
| BeiGene USA, Inc. | $80.80 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120853922 | CMS |
| Genmab U.S., Inc. | $124.99 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126827306 | CMS |
| Genmab U.S., Inc. | $124.99 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126827308 | CMS |
| Gilead Sciences, Inc. | $104.31 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133842749 | CMS |
| Gilead Sciences, Inc. | $103.10 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133842751 | CMS |
| Janssen Biotech, Inc. | $91.22 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078711255 | CMS |
| Merck Sharp & Dohme LLC | $10.85 | 02/09/2024 | Education | Undisputed | 01/23/2026 | 1141718298 | CMS |
| Merck Sharp & Dohme LLC | $10.85 | 04/17/2024 | Education | Undisputed | 01/23/2026 | 1141879707 | CMS |
| Merck Sharp & Dohme LLC | $10.85 | 06/11/2024 | Education | Undisputed | 01/23/2026 | 1141718314 | CMS |
| PFIZER INC. | $27.70 | 09/17/2024 | Education | Undisputed | 01/23/2026 | 1131621316 | CMS |
| Regeneron Healthcare Solutions, Inc. | $121.83 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114154288 | CMS |
| Regeneron Healthcare Solutions, Inc. | $17.02 | 10/01/2024 | Education | Undisputed | 01/23/2026 | 1114154293 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.